Endoparasiticidal agents for voluntary oral ingestion by animals

Details for Australian Patent Application No. 2001279664 (hide)

International Classifications

Event Publications

2 March 2006 Application Accepted

Published as AU-B-2001279664

15 June 2006 Opposition Lodged

Novartis AG has lodged an opposition against Bayer Aktiengesellschaft.

13 August 2009 Assignment before Grant

Bayer Aktiengesellschaft The application has been assigned to Bayer Animal Health GmbH 2003

18 February 2010 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 27 Oct 2009. Address for service in Australia - Davies Collison Cave 255 Elizabeth Street Sydney NSW 2000 2003

10 June 2010 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 27 Oct 2009 2002

2 February 2012 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 28 Oct 2011. Address for service in Australia - Davies Collison Cave Level 14 255 Elizabeth Street Sydney NSW 2000 2002

24 May 2012 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 28 Oct 2011 2004

9 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.